Skip to main content
OpenTrials

Clinical trial condition

Nephritis

Explore clinical trials studying Nephritis. Study availability and eligibility vary by location and protocol.

616 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Nephritis trial results

Completed

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

NCT04870333

Conditions
Autoimmune Diseases, COVID-19, Cardiovascular Diseases, +27 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom
  • NHS Lanarkshire - University Hospital Monklands Airdrie, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Betsi Cadwaladr University Health Board Bodelwyddan, United Kingdom
View all 45 locations
View Trial Details
Completed

A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL

NCT03019185

Conditions
Alport Syndrome, Collagen Diseases, Congenital Abnormalities, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Kidney Disease and Hypertension Research Services, PLLC Phoenix, Arizona, United States
  • Scripps Clinic, Nephrology La Jolla, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
View all 63 locations
View Trial Details
Completed

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

NCT03366337

Conditions
Abnormalities, Multiple, Autoimmune Diseases, Autosomal Dominant Polycystic Kidney, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenician Centers for Research & Innovation (PCRI) Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Denver Nephrology Denver, Colorado, United States
View all 30 locations
View Trial Details
Completed

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

NCT01613118

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +9 more
Locations
  • Balboa Nephrology Medical Group San Diego, California, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • Colorado Kidney Care Denver, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 33 locations
View Trial Details
Completed

Rituximab and RASi in Patients with IgAN

NCT04525729

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions